Trial Details
RECRUITINGBasic Information
| Clinical ID | c200 |
|---|---|
| Identifier | NCT06979336 |
| Trial Title | A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: RO7837195|DRUG: RO7837195 Matched Placebo |
Participant Information
| Sponsor | Genentech, Inc. |
|---|---|
| City | Lancaster |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2025-09-29 |
|---|---|
| Primary Completion Date | 2027-08-25 |
| Completion Date | 2028-10-31 |